Safety is paramount in vaccine clinical trials and temporary suspensions are not unusual to evaluate any unexplained illness in a participant, the World Health Organization (WHO) said on Thursday regarding the pause in an AstraZeneca COVID-19 trial.
AstraZeneca has suspended global trials of its experimental coronavirus vaccine after an unexplained illness in a participant, knocking the British drugmaker’s shares on Wednesday as prospects for an early rollout dimmed.
“We are pleased to see vaccine developers assuring the scientific integrity of the trials and abiding by the standard guidelines and rules for the development of vaccines,” the WHO said by email in response to a Reuters query. The WHO recommended “strict adherence to established testing protocols in all vaccine trials to ensure the safety of volunteers and the eventual safety and efficacy of vaccines”, it added.
Source: Vanguard
You may also like
Services Disrupted as UCH Unions Begin Five-Day Strike Over Power Rationing
Healthcare services at the University College Hospital (UCH), Ibadan, were …
Interswitch and Abia State Deploy eClinic to Digitise the State’s Healthcare Delivery
L–R: Babatunde Fadeyi, Vice President, Health Ecosystem (Public Sector), I…
Edo NMA Pushes Back Underhand Dealing Claims at UBTH as Management Increases Fees for Services
The Edo State Branch of the Nigeria Medical Association (NMA) has dismissed…
Drug-resistant infections surge in Lagos, NIMR scientist warns of post-antibiotic era
Senior Researcher at the Nigeria Institute of Medical Research (NIMR), Dr. …
Nursing and Midwifery Council of Nigeria (NMCN), in collaboration with the Nigeria Jubilee Fellows Programme (NJFP) 12 Month Paid Fellowship
The Nursing and Midwifery Council of Nigeria (NMCN), in collaboration with …
